TPMPA, a hybrid of isoguvacine and 3-APMPA, is the first selective antagonist for a GABAC receptor (KB = 2.1 µM), but not to interact with GABAA (KB = 320 µM) or GABAB receptors (EC50 = 500 µM). TPMPA has the potential for the research of suppressing orientation selectivity in ganglion cells[1][2][3].
Molecular Weight:
161.14
Purity:
98.1
CAS Number:
[182485-36-5]
Formula:
C6H12NO2P
Target:
GABA Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
